Research advancement in immunopathogenesis of myasthenia gravis
Open Access
- 3 February 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Neuroscience Bulletin
- Vol. 26 (1), 85-89
- https://doi.org/10.1007/s12264-010-0604-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Interleukin-10 promoter polymorphisms in myasthenia gravisJournal of Neuroimmunology, 2009
- BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDOEuropean Journal of Immunology, 2009
- Genetically determined neuromuscular disorders of some Roma families living in Hungary.2009
- Th17 and AllergyAllergology International, 2008
- Interleukine-6 (IL-6) may be a link between myasthenia gravis and myoepithelioma of the parotid glandMedical Hypotheses, 2007
- Th17 cell induction and immune regulatory effectsJournal of Cellular Physiology, 2007
- B cells in the pathophysiology of autoimmune neurological disorders: A credible therapeutic targetPharmacology & Therapeutics, 2006
- The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravisBlood, 2006
- Titin and ryanodine receptor antibodies in myasthenia gravisActa Neurologica Scandinavica, 2006
- Differential Estrogen Receptor Expression in Autoimmune Myasthenia GravisEndocrinology, 2005